RxDoctor Payments DataLook up a doctor →

Empaveli: payments to doctors

Payments that named Empaveli as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.2M
Providers
3,564
Transactions
5,970
Average per transaction
$206

The per-transaction average — $206 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,564 providers the average total is $346, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Apellis Pharmaceuticals, Inc.$1,194,93096.9%
Swedish Orphan Biovitrum AB$33,0052.7%
SOBI, Inc$4,7130.4%
← All drugs & devices